55 related articles for article (PubMed ID: 16377644)
1. Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study.
Kappler M; Krauss-Etschmann S; Diehl V; Zeilhofer H; Koletzko S
BMJ; 2006 Jan; 332(7535):213-4. PubMed ID: 16377644
[TBL] [Abstract][Full Text] [Related]
2. Patterns of clinical presentation of adult coeliac disease in a rural setting.
Jones S; D'Souza C; Haboubi NY
Nutr J; 2006 Sep; 5():24. PubMed ID: 16972991
[TBL] [Abstract][Full Text] [Related]
3. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study.
Lindfors K; Lin J; Lee HS; Hyöty H; Nykter M; Kurppa K; Liu E; Koletzko S; Rewers M; Hagopian W; Toppari J; Ziegler AG; Akolkar B; Krischer JP; Petrosino JF; Lloyd RE; Agardh D;
Gut; 2020 Aug; 69(8):1416-1422. PubMed ID: 31744911
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: the accuracy of serological tests to support the diagnosis of coeliac disease.
Sheppard AL; Elwenspoek MMC; Scott LJ; Corfield V; Everitt H; Gillett PM; Hay AD; Jones HE; Mallett S; Watson J; Whiting PF
Aliment Pharmacol Ther; 2022 Mar; 55(5):514-527. PubMed ID: 35043426
[TBL] [Abstract][Full Text] [Related]
5. Fly-catching syndrome responsive to a gluten-free diet in a French Bulldog.
Galli G; Uccheddu S; Menchetti M
J Am Vet Med Assoc; 2024 Mar; 262(3):1-3. PubMed ID: 38096663
[TBL] [Abstract][Full Text] [Related]
6. Colonic health: fermentation and short chain fatty acids.
Wong JM; de Souza R; Kendall CW; Emam A; Jenkins DJ
J Clin Gastroenterol; 2006 Mar; 40(3):235-43. PubMed ID: 16633129
[TBL] [Abstract][Full Text] [Related]
7. Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.
van der Sluys Veer A; Brouwer J; Biemond I; Bohbouth GE; Verspaget HW; Lamers CB
Dig Dis Sci; 1998 Mar; 43(3):590-5. PubMed ID: 9539656
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of lysozyme in the faeces.
Hemrika MH; Costongs GM; Engels LG; Bos LP; Janson PC; Flendrig JA
Neth J Med; 1989 Apr; 34(3-4):174-81. PubMed ID: 2725797
[TBL] [Abstract][Full Text] [Related]
9. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.
Gisbert JP; McNicholl AG; Gomollon F
Inflamm Bowel Dis; 2009 Nov; 15(11):1746-54. PubMed ID: 19363798
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
11. Relationship between fecal lactoferrin and inflammatory bowel disease.
Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
[TBL] [Abstract][Full Text] [Related]
12. Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction.
Stensvold R; Brillowska-Dabrowska A; Nielsen HV; Arendrup MC
J Parasitol; 2006 Oct; 92(5):1081-7. PubMed ID: 17152954
[TBL] [Abstract][Full Text] [Related]
13. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Löser C; Möllgaard A; Fölsch UR
Gut; 1996 Oct; 39(4):580-6. PubMed ID: 8944569
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Zhu F; Zhuang C; Chu K; Zhang L; Zhao H; Huang S; Su Y; Lin H; Yang C; Jiang H; Zang X; Liu D; Pan H; Hu Y; Liu X; Chen Q; Song Q; Quan J; Huang Z; Zhong G; Chen J; Han J; Sun H; Cui L; Li J; Chen Y; Zhang T; Ye X; Li C; Wu T; Zhang J; Xia NS
Lancet Respir Med; 2022 Aug; 10(8):749-760. PubMed ID: 35644168
[TBL] [Abstract][Full Text] [Related]
15. The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling.
Gangadoo S; Rajapaksha Pathirannahalage P; Cheeseman S; Dang YTH; Elbourne A; Cozzolino D; Latham K; Truong VK; Chapman J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671197
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease.
Maglio M; Troncone R
Front Nutr; 2020; 7():73. PubMed ID: 32548124
[TBL] [Abstract][Full Text] [Related]
17. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
[TBL] [Abstract][Full Text] [Related]
18. Gluten sensitivity presenting as a neuropsychiatric disorder.
Genuis SJ; Lobo RA
Gastroenterol Res Pract; 2014; 2014():293206. PubMed ID: 24693281
[TBL] [Abstract][Full Text] [Related]
19. ACG clinical guidelines: diagnosis and management of celiac disease.
Rubio-Tapia A; Hill ID; Kelly CP; Calderwood AH; Murray JA;
Am J Gastroenterol; 2013 May; 108(5):656-76; quiz 677. PubMed ID: 23609613
[TBL] [Abstract][Full Text] [Related]
20. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
